LDHAL6B is a novel prognostic marker and promotes disease progression in multiple myeloma

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2025-05-08
DOI
https://doi.org/10.3324/haematol.2024.286835
Citations
1
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
1.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LDHAL6B is a novel prognostic marker and promotes disease progression in multiple myeloma

Shanshan Luo, Fei Zhao, Yu‐Wen Hu, Fengjuan Fan et al.
1 citations
Haematologica
Multiple Myeloma Research and Treatments
1.77
article

LDHAL6B is a novel prognostic marker and promotes disease progression in multiple myeloma

Shanshan Luo, Fei Zhao, Yu‐Wen Hu, Fengjuan Fan, Yuhuan Zheng, Li Cai, Bo Zhang, Qun Li, Zhixin Li, Chunyan Sun, Liping Zuo
article en
1 citations

Abstract

No abstract available for this paper.
HaematologicaVol. 110(11)
Sichuan University (CN), West China Hospital of Sichuan University (CN), Huazhong University of Science and Technology (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 17%
Multiple Myeloma Research and Treatments
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.